Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
19
Number of overlapping holdings
26.4%
% of CNCR's 72 holdings also in SBIO
21.3%
% of SBIO's 89 holdings also in CNCR
Overlap by Weight
Sector Drift (CNCR minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CNCR |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
ARCELLX, INC. | 1.7% | 3.2% | 1.7% |
|
GERON CORP | 1.4% | 1.7% | 1.4% |
 |
MERUS N.V. | 1.4% | 2.2% | 1.4% |
|
XENCOR INC | 1.8% | 1.1% | 1.1% |
|
IDEAYA BIOSCIENCES, INC. | 1.1% | 1.5% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
CNCR Overweight Relative to SBIO
|
RECURSION PHARMACEUTICALS, INC CLASS | 3.3% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | 2.4% |
|
MONTE ROSA THERAPEUTICS, INC. | 2.1% |
|
EXELIXIS INC | 2.0% |
|
JANUX THERAPEUTICS, INC. | 1.9% |
|
BRISTOL-MYERS SQUIBB CO | 1.8% |
|
MERSANA THERAPEUTICS, INC. | 1.7% |
|
BLUEPRINT MEDICINES CORP. | 1.7% |
|
SPRINGWORKS THERAPEUTICS, INC. | 1.7% |
|
SCHRODINGER, INC. | 1.7% |
CNCR Underweight Relative to SBIO
|
CORCEPT THERAPEUTICS INC | -4.2% |
 |
ALKERMES PLC | -3.6% |
|
KRYSTAL BIOTECH, INC. | -3.4% |
|
CRINETICS PHARMACEUTICALS INC | -3.1% |
|
AVIDITY BIOSCIENCES INC | -2.7% |
|
PTC THERAPEUTICS INC | -2.5% |
|
DENALI THERAPEUTICS INC. | -2.3% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -2.1% |
|
ACADIA PHARMACEUTICALS INC | -2.1% |
|
VERICEL CORPORATION | -2.0% |